Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

NCT00562549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: SLx-2101

Sponsor

Retension Pharmaceuticals. Inc.